Synergistic Inhibition of Nasopharyngeal Carcinoma by Biyan Qingdu Granule and Micro-Radiation: An Experimental Study
Download PDF
$currentUrl="http://$_SERVER[HTTP_HOST]$_SERVER[REQUEST_URI]"

Keywords

Biyan Qingdu Granule
Nasopharyngeal carcinoma
Radiotherapy
Tumor necrosis factor
Interleukin
Vascular endothelial cell adhesion molecule

DOI

10.26689/par.v8i6.8918

Submitted : 2024-10-26
Accepted : 2024-11-10
Published : 2024-11-25

Abstract

Objective: To investigate the role of Biyan Qingdu Granule combined with micro-radiation in suppressing nasopharyngeal carcinoma and to explore its mechanism of action. Methods: FAT cells of nasopharyngeal carcinoma were injected into the hind limb axilla of F344 rats to establish a rat nasopharyngeal carcinoma tumor model. X-ray radiation was applied to the oral cavity of the rats, delivering a micro-dose of radiation to the distant hind limb axilla tumor. The general condition of the rats, including oral mucosal inflammation, the size of the nasopharyngeal tumor mass, pathological changes in the tumor tissue, and the levels of TNF-α, IL-1β, IL-6, IL-18, IL-12, ICAM-1, and VCAM-1 in the tumor tissue, were assessed. Results: Oral administration of Biyan Qingdu Granule improved the rats’ overall condition and reduced oral mucosal inflammation. Pathological examination revealed tumor cell degeneration and necrosis. ELISA analysis of tumor tissue showed significant reductions in TNF-α, IL-1β, IL-6, ICAM-1, and VCAM-1 levels, along with a notable increase in IL-18 levels. Conclusion: Biyan Qingdu Granule, when combined with micro-radiation, can inhibit tumor growth and reduce tumor volume. Its mechanism of action may involve enhancing immune function and suppressing inflammatory factors.

References

Chow JC, Ngan RK, Cheung KM, et al., 2019, Immunotherapeutic Approaches in Nasopharyngeal Carcinoma. Expert Opin Biol Ther, 19(11): 1165–1172. https://doi.org/10.1080/14712598.2019.1650910

Guo R, Mao YP, Tang LL, et al., 2019, The Evolution of Nasopharyngeal Carcinoma Staging. Br J Radiol, 92(1102): 20190244. https://doi.org/10.1259/bjr.20190244

Zhou Z, Li K, Li N, et al., 2023, Age-Period-Cohort Analysis of Incidence and Mortality Trends of Nasopharyngeal Carcinoma in the Chinese Population. Chinese Journal of Disease Control and Prevention, 27(8): 869–876 + 894.

Xiao B, Wang P, Zhao Y, et al., 2021, Using Arterial Spin Labeling Blood Flow and Its Histogram Analysis to Distinguish Early-Stage Nasopharyngeal Carcinoma from Lymphoid Hyperplasia. Medicine (Baltimore), 100(8): e24955. https://doi.org/10.1097/MD.0000000000024955

DeRenzo C, Lam C, Rodriguez-Galindo C, et al., 2019, Salvage Regimens for Pediatric Patients with Relapsed Nasopharyngeal Carcinoma. Pediatr Blood Cancer, 66(1): e27469. https://doi.org/10.1002/pbc.27469

Shi Z, Lin J, Yang B, et al., 2024, Effect and Mechanism of Biyan Qingdu Granules on Reversing Cisplatin Resistance in Nasopharyngeal Carcinoma Cells by Regulating Copper Ion Transporter CTR1. Drugs & Clinic, 39(8): 1937–1943.

Wang X, Wang M, Xu X, et al., 2024, Protective Effect of Biyan Qingdu Granules on Inflammatory Injury of Radioactive Oral Mucositis of Nasopharyngeal Carcinoma and Its Mechanism. Drug Evaluation Research, 47(5): 1063–1070.

Chen Y, Chang ET, Liu Z, et al., 2021, Residence Characteristics and Risk of Nasopharyngeal Carcinoma in Southern China: A Population-Based Case-Control Study. Environ Int, 151: 106455. https://doi.org/10.1016/j.envint.2021.106455

Mi X, Liu L, Li S, et al., 2017, Experimental Study of Tumor-Specific CTL Induced by rmIL-18 Treated on Hepatocellular Carcinoma. Chinese Journal of Immunology, 2017(12): 545–548.

Mu Y, Zhao H, Zhang J, et al., 2019, Study on the Antitumor Effect of Transient Overexpression of IL-12 in Hepatocellular Carcinoma Cells. Chinese Journal of Immunology, 35(23): 2864–2868.

Zhu L, Wang D, Feng X, et al., 2024, Effect of Huangqintang on Inflammation and Short-chain Fatty Acid-related Gut Microbiota in Mouse Model of Inflammation-associated Colorectal Cancer. Chinese Journal of Experimental Traditional Medical Formulae, 30(23): 157–169.